Exceptional companies tackling problems that matter.

A wholly owned subsidiary of the Charles H. Hood Foundation.

DIAGNOSTICSInfectious disease diagnostics that facilitate society's collective response to global health emergencies

biopharmaSafe, effective treatment for retinopathy of prematurity

digital healthClinical decision support tool for ASD and other neurological conditions

diagnosticsDeveloping the first broad-spectrum blood test for Autism Spectrum Disorders

medtechReducing infant mortality and morbidity in low-resource settings

biopharmaNeuroprotectant for use in neonatal hypoxic-ischemic encephalopathy

medtechLightweight MRI-receive coils designed for pediatric patients

biopharmaTargeted therapy for bone and muscle wastage in Duchenne muscular dystrophy

medtechChanging the standard of care for preterm infant feeding

biopharmaTargeted bacteria-mediated therapy for patients with neurofibromatosis Type 2

medtechAffordable life-saving medical innovations for healthcare in emerging markets

DIGITAL HEALTHBedside empowerment technology for parents with babies in the NICU

medtechNoninvasively monitoring central venous oxygenation

exit · medtechRevolutionizing umbilical catheter protection and securement

DIGITAL HEALTHGenetic insights for newborns with ongoing genomic-guided care

biopharmaBiologic therapy to prevent and treat necrotizing enterocolitis in newborns

medtechTreating Neonatal Opioid Withdrawal Syndrome and other infant respiratory disorders

medtechTechnology to prevent blindness in premature babies

medtechRevolutionary infant spinal tap positioning solution

biopharmaENPP1 blocking cancer therapies

digital healthProviding clinical knowledge to everyone, everywhere — starting with children

medtechNonsurgical eardrum repair treatment - replaces traditional tympanoplasty with a clinic-based procedure

* Springhood has no direct interest in the companies in the CH Innovations Portfolio. Mr. Parker manages this portfolio as a trustee of the Charles H. Hood Foundation. It is shared here for illustrative purposes only.